
J. Fraser Stoddart, Nobel winner for work in nanotechnology
J. Fraser Stoddart was a professor at Northwestern University for 16 years who shared the Nobel Prize in chemistry in 2016 for advancements in the field of nanotechnology, which involves the manipulation of individual atoms and molecules.
In the early 1990s, Stoddart worked on the development of rotaxane, a dumbbell-shaped molecule that can be used as an artificial molecular machine. His work introducing this mechanical bond into chemical compounds paved the way for scientists to create artificial molecular switches and motors that have the potential for use in fields from health care to technology.
A prolific writer and teacher, Stoddart authored more than 1,300 scientific papers and oversaw more than 500 graduate and postdoctoral students.
'Fraser was a visionary with an infectious passion for chemistry and a larger-than-life presence that inspired everyone around him,' said Omar K. Farha, chairman of Northwestern's chemistry department and a professor of chemistry. 'His passion for chemistry was evident in everything he did.'
Stoddart, 82, died of cardiac arrest on Dec. 30 in a hotel in Australia while on vacation, said his daughter, Alison. Most recently a Hong Kong resident, Stoddart also had a home in Chicago's River North neighborhood and previously lived in Evanston.
Born in Edinburgh, Scotland, James Fraser Stoddart grew up on a farm just south of Edinburgh and commuted to a day school in Edinburgh, his daughter said. His interest in science stemmed from his father's scientific approach to farming, his daughter said. Stoddart was also interested in puzzles — anything from jigsaw puzzles to building kits like Meccano construction sets, she said.
After earning bachelor's and doctoral degrees in chemistry from the University of Edinburgh, Stoddart worked as a postdoctoral fellow at Queen's University in Ontario, Canada. In 1970, he returned to the British Isles, working first as a research fellow and then as a faculty lecturer, or assistant professor, at the University of Sheffield.
By the late 1970s, Stoddart had become intrigued with the idea of what would become nanotechnology. He briefly worked at a corporate lab in Runcorn, England, where he investigated technically interlocked molecules. In 1981, he returned to the University of Sheffield, where he was made an associate professor. In 1990, he moved to the University of Birmingham, also in England, to chair its organic chemistry department. He headed the school of chemistry there from 1993 until 1997.
While in Birmingham, Stoddart developed a rotaxane molecule through an intricate process threading a molecular ring onto a thin molecular axle and then showing that the ring could move along the axle. Stoddart's work allowed others to create artificial molecular switches and motors, which could be controlled chemically, electrically and optically.
Ultimately, Stoddart's work allowed scientists to construct molecular machines that act like muscles, and can be manipulated accordingly. While still early in development, such devices in theory could be used to battle disease, in lifesaving therapeutic systems, for example.
In 1997, Stoddart left the University of Birmingham to take a job as a professor at the University of California-Los Angeles.
In 2007, Stoddart and his team of 20 researchers left UCLA to work at Northwestern as part of what the Tribune reported was the university's drive to become the undisputed leader in the emerging field of nanotechnology. Stoddart told the Tribune that he was a 'scientific nomad' and touted Northwestern as 'the magnet drawing people into nanotechnology.'
In 2016, Stoddart was awarded the Nobel Prize in chemistry, sharing it with French chemist Jean-Pierre Sauvage, whose work in 1983 involved bonding two molecules mechanically rather than chemically, and Dutch chemist Bernard L. 'Ben' Feringa, whose research has focused on molecular rotary motors. The three were cited for developing molecules 'with controllable movements, which can perform a task when energy is added,' the Nobel Foundation announced in a release.
Stoddart and his fellow 2016 chemistry Nobel laureates 'have taken molecular systems out of equilibrium's stalemate and into energy-filled states in which their movements can be controlled,' the foundation said. 'In terms of development, the molecular motor is at the same stage as the electric motor was in the 1830s, when scientists displayed various spinning cranks and wheels, unaware that they would lead to washing machines, fans and food processors. Molecular machines will most likely be used in the development of things such as new materials, sensors and energy storage systems.'
Stoddart said the Nobel award took him by surprise.
'This has been going on for 22 years or something, and I really reached the point where I didn't think it would ever happen,' he told the Tribune in 2016.
Stoddart's Northwestern colleagues praised his pioneering work, as well as his abilities as a communicator and mentor.
'He was a creative genius when it came to chemistry,' said Chad Mirkin, a Northwestern chemistry professor. 'His passion for science and command of the English language were unmatched. He saw things that others didn't, and this led to the discovery of the mechanical bond, which became the basis for much of the molecular machine work being pursued today. Few move the needle at storied research universities like Northwestern — his impact was immediate and will be felt for decades.'
Farha lauded Stoddart's ability to inspire others, simplify complex ideas and create a collaborative, uplifting environment.
'Fraser combined brilliance, humility and genuine care for others, building a global community united by respect and love for chemistry,' Farha said. 'He excelled at pioneering new fields, inspiring curiosity through storytelling and mentoring future generations of scientists.'
Stoddart left Northwestern in 2023 to take a job as a professor of chemistry at the University of Hong Kong.
Stoddart's wife, Norma, a biochemist, died in 2004. Stoddart is also survived by another daughter, Fiona McCubbin; and five grandchildren.
A funeral service will take place in February in Edinburgh.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 hours ago
- Yahoo
Protect LIGO's science and local impact from Trump's budget cuts
The Trump administration wants to slash funding for America's two Laser Interferometer Gravitational-wave Observatories (LIGOs) as part of broader cuts to the National Science Foundation. That would be a devastating blow to the nation's global leadership in scientific research. When Congress writes its fiscal 2026 budget, it should ignore the president's anti-science request. One of the LIGO sites is on the Hanford nuclear site. The other is in Louisiana. The White House proposes cutting 40% of their funding – $48 million to $29 million. And it also dictates how that cut should be made. It wants one of the two sites shut down. Given that Washington is a blue state that is participating in multiple lawsuits against the Trump administration and Louisiana is a red state that voted for the president, the odds of LIGO Hanford surviving seem low. Either way, scientists' ability to explore the universe by detecting gravitational waves would suffer significantly. Shutting one site down would compromise scientists' ability to verify detections of cosmic events and weed out false readings originating from local disturbances. It also would prevent the two sites from triangulating where an event occurred in the sky, allowing telescopes that rely on light for observations to also find and research them. The two LIGOs work in tandem. In 2015, the Hanford observatory and its sibling in Louisiana detected gravitational waves for the first time when they measured the ripple in space-time caused by two black holes merging 1.4 billion light-years away. The findings provided fresh confirmation of Albert Einstein's theory of general relativity and earned researchers a Nobel Prize in physics. Since then, LIGO has detected hundreds of events, including black holes merging and neutron stars colliding. The Hanford site continues to refine its tools and push science forward. An upgrade a couple of years ago installed quantum squeezing technology that allows scientists to detect 60% more events and probe a larger volume of space. If funded, the observatories will continue to help humanity answer profound questions about the universe. Projects like LIGO are expensive. The National Science Foundation has spent more than $1 billion on detecting gravitational waves over four decades. At the start, skeptics deemed it risky, but it has provided tremendous return on investment. It epitomizes the sort of Big Science research that few institutions other than governments can afford. Think Europe's Large Hadron Collider, the Manhattan Project and the international Human Genome Project. Undercutting LIGO as it reaches its full potential and produces its most impressive results just to save a few million dollars would be a colossal mistake. As one commenter on the Tri-City Herald's website put it, 'It would be like inventing the microscope, seeing a cell for the first time, and then discarding it.' The best is yet to come. Even if a future administration were to restore funding, rehiring skilled researchers would be a monumental hurdle. A temporary shutdown will delay scientific progress and result in America losing ground to international researchers. LIGO has a local impact, too, and not just that it is visible from outer space. Its presence helps the Tri-Cities and the Hanford nuclear site evolve their scientific narrative from Cold War-era nuclear development to 21st-century astrophysics. It is a symbol of progress, diversification and positive global contribution that is invaluable for regional identity and attracting future talent and investment. LIGO staff go the extra mile by working with local STEM (science, technology, engineering and mathematics) students. They speak in classrooms about science careers and explain the complex workings of the observatory in a way that young people can understand. An $8 million LIGO Exploration Center, which opened in 2022 and was funded by Washington state, further enhances that public-facing mission. Such direct engagement cultivates future STEM talent and inspires the next generation of scientists and engineers. The proposed cuts to LIGO would lead to an irreversible loss of U.S. leadership in gravitational wave astronomy and an immense loss to the Tri-Cities. The Trump administration must reconsider. If it does not, Washington's congressional delegation must convince their colleagues to preserve this cornerstone of American scientific preeminence.


New York Post
2 days ago
- New York Post
Menopause drug might prevent breast cancer and treat hot flashes, research finds
A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, 'significantly reduced' breast tissue cell growth, which is a major indicator of cancer progression. Advertisement A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, according to a press release from Northwestern. This non-invasive breast cancer affects more than 60,000 American women each year, often leading to an outcome of invasive breast cancer. The women were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Duavee is a conjugated estrogen/bazedoxifene (CE/BZA) drug, which combines estrogen with another medication that minimizes the potential harmful side effects of the hormone. Advertisement 'The key takeaway from the study is that CE/BZA slows the growth (proliferation) of cells in milk ducts of DCIS that expressed the estrogen receptor significantly more than placebo,' Dr. Swati Kulkarni, lead investigator and professor of breast surgery at Northwestern University Feinberg School of Medicine, told Fox News Digital. 5 New research from Northwestern University found that the drug Duavee 'significantly reduced' breast tissue cell growth, a major indicator of cancer progression. Marko Geber – Another major finding is that the quality of life did not differ significantly between the two groups, but patients who took the CE/BZA reported fewer hot flashes during the study, she noted. 'This would be expected, as the drug is FDA-approved to treat hot flashes.' Advertisement Kulkarni presented the study last week at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. 5 The women in the study were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Gorodenkoff – 5 Those who took the drug reported fewer hot flashes during the study. fizkes – The findings are preliminary and have not yet been published in a medical journal. Advertisement 'What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer,' said the doctor, who is also a Northwestern Medicine breast surgeon. Women who face a higher risk of breast cancer — including those who have experienced 'high-risk lesions' — and who also have menopausal symptoms are most likely to benefit from the drug, according to Kulkarni. 'These women are typically advised against standard hormone therapies, leaving them with few menopausal treatment options,' the release stated. Study limitations The researchers said they are 'encouraged' by these early results, but more research is required before the medication can be considered for approval as a breast cancer prevention mechanism. 'Our findings suggest that CE/BZA may prevent breast cancer, but larger studies with several years of follow-up are needed before we would know this for sure,' Kulkarni told Fox News Digital. Dr. Sheheryar Kabraji, chief of breast medicine at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, was not involved in the study but commented on the findings. 5 'What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer,' Dr. Swati Kulkarni said. sarayutsridee – Advertisement 'While intriguing, this study is highly preliminary, and more research will be needed before we can conclude that conjugated estrogen/bazedoxifene (CD/BZA), a form of the hormone estrogen commonly prescribed to address symptoms of menopause, prevents invasive breast cancer or is effective at reducing cancer risk,' he told Fox News Digital. Kabraji also noted that the study focused on reducing levels of one specific protein, 'which does not always predict reduced recurrence of breast cancer.' 'This study did not directly show that CE/BZA treatment reduces the risk of DCIS recurrence or development of invasive cancer,' he noted. 5 According to Kulkarni,'larger studies with several years of follow-up are needed' to confirm that the drug prevents breast cancer. Science RF – Advertisement 'Importantly, however, patients who received this therapy experienced no worsening of quality of life, and saw improvement in vasomotor symptoms, such as hot flashes. If found to be effective in preventing breast cancer, CE/BZA is likely to have fewer side effects than current medications used for breast cancer prevention.' Lead researcher Kulkarni emphasized that this medication is not for the treatment of invasive breast cancer or DCIS. 'Right now, we can say that women who are concerned about their risk of developing breast cancer can consider this medication to treat their menopausal symptoms,' she added.

Yahoo
2 days ago
- Yahoo
Worried Northwestern lab directors describe ‘bleak' atmosphere in wake of Trump research funding freeze
The Trump administration's freezing in April of $790 million in federal research funding for Northwestern University has left concerned lab directors without key grants from the National Institutes of Health and forced the university to spend millions to keep vital research afloat and to continue to pay graduate workers and scientists. Carole LaBonne, a professor of molecular biosciences at Northwestern, said the situation at the prominent research institution can only be described as 'bleak' as the halt in federal funds continues to send shockwaves across the Evanston campus. 'You're at risk of losing an entire next generation of scientists, and these are the researchers who are going to be driving tomorrow's discoveries and cures,' LaBonne told the Tribune. 'It has short-term impacts, it has long-term impacts — it's terrifying; it's completely senseless.' Northwestern officials did not confirm how much the university is spending to keep research going there, but LaBonne said that is widely known among the science faculty, who were recently notified by the dean of the Weinberg College of Arts and Sciences in a meeting that it is costing Northwestern more than $10 million a week. 'The university is working very hard to advocate on behalf of research and our researchers,' a Northwestern spokesperson said in a statement. 'Our lifesaving research improves our society and has a multibillion-dollar impact on our economy.' In recent letters to the campus community, Northwestern President Michael Schill and other administrators said the university has received about 100 stop-work orders, mostly Department of Defense-funded research projects, and about 50 grant terminations. In addition, officials said Northwestern researchers have not received payments for National Institutes of Health grants since March, signaling that those funds have been frozen, despite no official word from the Trump administration. They also wrote that the university would continue to fund research affected by stop-work orders and the federal funding freeze. 'This support is intended to keep these projects going until we have a better understanding of the funding landscape,' the officials wrote. 'We expect and hope to recoup the costs of this research once federal funding is restored. However, this commitment places significant financial stress on the University and is not a permanent solution.' LaBonne said the scientific community at Northwestern is living in 'existential dread' as the question of how the university can continue to sustain big-budget research without grant reimbursements looms large. 'Financially, you're going to cripple universities. And when you cripple universities, you're going to cripple not only our health and scientific discoveries in this country, but also our economy,' she said. 'The federal government depends on universities to conduct the research that keeps our nation healthy, safe and economically competitive.' Part of LaBonne's lab work at Northwestern touches on pediatric cancers, and NIH funding has historically fueled breakthroughs in cancer treatments. 'Forty years ago, more than 60% of children that were diagnosed with cancer would have died within five years of the diagnosis. Today, there's a 90% survival rate,' she said. For years, work in LaBonne's lab has centered on understanding the normal development of the neural crest — a stem cell population central to the evolution of the vertebrates — and understanding how cancer can result from the aberrant development of this cell type. Such research never ends, LaBonne said, adding that she fears that some long-standing research programs won't be sustainable for much longer with federal funding in limbo. Sadie Wignall, a molecular biosciences professor at Northwestern, agrees. 'There is a lot of anxiety and apprehension because of the uncertainty of the situation, and that uncertainty is what is very difficult to navigate,' said Wignall. 'Many research labs here have NIH funding. I run my lab entirely off NIH funding. Am I going to be able to continue to pay the staff in my lab? Am I going to be able to continue to take graduate students into my lab?' Two NIH grants pay the salaries of four doctoral students and two research scientists in the Wignall Lab, which is investigating the dynamics and mechanics of how reproductive cells divide. Wignall also directs the Interdisciplinary Biological Sciences Graduate Program, which trains graduate students to get postdoctorates in biomedical science on the Evanston campus. The funding freeze affects those early-career scientists, she said, explaining that students go through three 10-week lab rotations culminating in a match system. But uncertain funding means labs can't take new doctoral students to train them, which means fewer students get the opportunity to study and work at Northwestern's myriad research facilities. 'We're right at that point of the year for our first-year class where they've been rotating through different research labs to try to decide where they want to do their Ph.D. research, but with the funding freeze and canceled grants, there are now a lot of labs that thought they wanted to recruit a student this year and now can't,' Wignall said. 'If current first-years can't find a lab to join, they'll likely have to exit the Ph.D. program.' How federal funding works At the beginning of every grant year, the NIH or the National Science Foundation sends a Notice of Award detailing approval for a certain amount of spending in the next grant year, but a check isn't sent to Northwestern. It's essentially an 'IOU,' explained Wignall. 'So as I make purchases on my grant and as I pay salaries, Northwestern sends an invoice to the NIH that says, 'Professor Wignall has charged these approved funds, please reimburse us,'' she said. 'That usually happens about every two weeks — an invoice is sent for every NIH grant to the NIH, then they send a check to cover that spending. And then at the end of the year, just like you do in a bank account, you have your balance. You try to spend down to zero on approved funds.' Northwestern recently has been submitting those requests to the NIH, hoping that the money will flow again, but nothing has been reimbursed since late March. 'All of the labs that are doing research are basically accumulating debt because we're spending money that we were promised, but it's not being sent, and the university is the one on the hook for that money right now,' Wignall said. The Trump administration's decision to freeze nearly all of Northwestern's annual federal research funding stems from federal investigations into allegations of antisemitism and civil rights violations at the university amid the school's handling of pro-Palestinian demonstrations on campus. The Trump administration also froze $1 billion in federal funds for Cornell University and stripped more than $2 billion in federal grants from Harvard University and blocked its international student enrollment. The administration also has ordered U.S. embassies and consular sections to stop scheduling new interviews for student visa applicants. LaBonne and other academics are highly skeptical of the Trump administration's reasoning, particularly the claims of widespread antisemitism on campus. 'Just about everything they're doing was clearly laid out in the Heritage Foundation's Project 2025 and that happened before Oct. 7 — before the encampments on campus,' LaBonne said. 'None of this has to do with any of that. It's about hurting universities, and why you would want to do that when they're so centrally important to our scientific research enterprise and the economics of the U.S. is mind-blowing.' Wignall, like LaBonne and other lab directors, said she's 'extremely grateful' to the board of trustees and the administration for helping to support their research. LaBonne said support is crucial, not just for the research itself but also because research labs train scientists, and science majors at top research universities expect hands-on training in faculty labs. 'But all of us researchers understand that the university can't support us forever and at some point they're going to have to shut down some labs. It's very uncertain if my lab will be fine a month from now or two months from now,' Wignall added. A tiny pacemaker fit for newborn babies At Northwestern's Efimov Lab in Chicago, research associate Eric Rytkin is working with a team of graduate students on several projects, including the world's smallest pacemaker. Their study, published in the journal Nature, demonstrates that the device, which is smaller than a grain of rice, can be non-invasively placed in the body. And although it is suitable for hearts of all sizes, researchers say the pacemaker is particularly beneficial to the tiny, fragile hearts of newborn babies with congenital heart defects. The project was made possible through an NIH grant, Rytkin said, and a new grant was issued recently, but the award has yet to be distributed. Still the pacemaker project remains secure, Rytkin said, thanks to Northwestern and interest from the national scientific community. But another project — a device aimed at delivering painless shocks to defibrillate the heart — is being tabled. 'I can say that everything here boils down to the quality of life of patients. Of course there are lifesaving therapies, but whether these lifesaving therapies will be well tolerated by this person, and whether it will affect their physical or moral well-being of that person is equally as important as the years of life,' Rytkin said. Rytkin said while it's common in the industry to prioritize certain research projects over others, it isn't ideal to have to put ideas on the back burner. 'As researchers we would like to have academic freedom to explore other ideas which are not aimed at immediate gain or immediate profit, but may have and may result in wonderful spinoffs and technological models at a later date,' Rytkin said. 'And if the devices are getting translated, it's the most likely path that they're going to be acquired by some big corporation like Medtronic, Boston Scientific, Abbott — they're all American companies.' Lichao (James) Tang, a joint Ph.D. student who earned a master's in biomedical engineering from Northwestern University, performed surgeries on lab animals during the pacemaker development. Tang said the hope is for the pacemaker to be clinically tested in humans in five years, but that might now hinge on federal funding. NIH spending also supports Tang's salary. 'The freeze affects our overall lab budget, because we have a lot of money to spend, either to purchase research animals, or to purchase materials, to fabricate devices,' Tang said. 'We can only buy the things that are super necessary right now.' Like many of his colleagues involved in research labs, Tang has concerns about the future of science and research. 'I've been in the U.S. for a very long time, but prospective students will definitely have (to think about their choices). Without all the issues with federal funding and student visas, I think America would definitely be their top choice,' said Tang, who is from China. 'It's getting harder to even get a student visa right now. And even if you come here, say for a Ph.D. program where you have at least a five-year commitment, the current uncertainty would make students think, 'If I come here, what if my funding is not guaranteed?'' Attracting top talent from other countries The halt in student visa interviews and the funding freeze will make it much more difficult for the U.S. to attract top minds from around the world, experts say. 'The reality is that there is a race for global talent around the world,' said Fanta Aw, executive director and CEO of NAFSA: Association of International Educators. 'The truth of the matter is, international students are going into fields like STEM that are in very high demand, but where there's a massive skill gap that exists in this country. These students are playing a very critical role in filling this gap that we're seeing.' A recent NAFSA breakdown looks at the national and state benefits from international students and how much money they've contributed to universities and colleges. According to the data, international students at the University of Illinois Urbana-Champaign have contributed $567.5 million to the local economy and supported 6,158 jobs; at the University of Chicago, $428.1 million and 4,965 jobs; at Northwestern, $323.7 million and 3,573 jobs; and the University of Illinois Chicago, $184.9 million and 1,886 jobs. LaBonne said the cuts are detrimental to many sectors of the U.S. 'The government doesn't fund university labs to help universities' bottom line — it funds the best ideas and people to meet national priorities,' she said. 'The resulting discoveries spill over to benefit all of society: new medicines, new companies, new military capabilities. This has been called one of the most productive partnerships in American history.' Academics have long argued that federally funded technologies like the revolutionary-gene editing tool CRISPR, CAR-T Therapy for cancer, vaccines and research unlocking treatments for diseases such as ALS and Alzheimer's are solid arguments for why Congress and the White House should ensure consistent and robust funding for science. LaBonne said the funding decreases touch virtually every area of science and goes far beyond the diversity, equity and inclusion programs the Trump administration wants to cut. An April executive order from the Trump administration mandated the elimination of DEI-related programs in federal agencies, resulting in the NSF canceling hundreds of project grants at universities. In February, U.S. Sen. Ted Cruz published a list identifying more than a third of the NSF grants that were being terminated, of which a handful were Northwestern grants. In a statement, the NSF said it has undertaken a review of its award portfolio. 'The agency has determined that termination of certain awards is necessary because they are not in alignment with current NSF priorities,' NSF officials said. On its website, the NSF said it is canceling awards that are not in line with its priorities, including those focused on DEI, environmental justice and 'misinformation/disinformation.' According to Grant Watch — a website that tracks the termination of scientific research grants under the Trump administration — more than 20 NIH grants related to research into HIV/AIDS, child development, substance use, vaccine hesitancy in Black communities, family planning and more were canceled at Northwestern. Lab directors at Northwestern noted there's a rigorous process for procuring federal grants each submission cycle. After a proposal is submitted, 20 to 30 scientists from across the country with subject matter expertise review the proposal and give them scores. Months later, another advisory council approves the recommendations and greenlights a federal grant. 'This is not easy money; this is highly competitive for the best ideas and the best processes,' LaBonne added. Wignall, who's said she's trying to stay positive despite the chaos, said the cost of stripping resources away from scientific research is insurmountable and will have an impact far beyond the current political situation. 'I think this is going to have a really chilling effect on future generations of students, because people will look at this career and say that science is not a safe career — It's too dependent on political whims,' Wignall said. 'Traditionally, science has been science. Support for science has been very bipartisan and we really hope that we can turn this around … otherwise we're really going to lose our excellence as a nation.'